Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-05

Clinical Trial Update: Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on nighttime losartan in continuous ambulatory peritoneal dialysis for patients with hypertension and nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan (losartan)

Snippet

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University | Conditions: Hypertension,Nephropathy | Phase 4 | Status: UNKNOWN